Safety In Breast Implants: Insights From The UK Parliament — Part 1: A Scientific Perspective

€29,95 (incl. VAT)

This is a condensed version of an oral evidence session held by the UK House of Commons Women and Equalities Committee on May 14, 2025. The main purpose of the session was to investigate the health impacts of breast implants and other cosmetic procedures, with a particular focus on the safety concerns and regulatory issues surrounding PIP (Poly Implant Prothèse) breast implants.

The first part of the session focuses on the scientific and medical risks of breast implants. The discussion centers on the health hazards, immune responses, and the need for better data and post-market surveillance.

Add to cart Buy now

32 Minutes | 0.5 CME credit | Rating N/A | Accredited until 6 March 2027 

Details

Details

Duration: 32m
CME credit: 0.5
Rating: N/A

+ 
Language: English
+ Available since: 10 June 2025
+ Accredited at least until: 6 March 2027

Target group

Plastic and reconstructive surgery
Cosmetic surgery
General surgery
General practice / Family medicine
Internal medicine
Allergy & Immunology
Gynecology

Plastic and reconstructive surgery
Cosmetic surgery
General surgery
General practice / Family medicine
Internal medicine
Allergy & Immunology
Gynecology


Target group

Target group

Learning objectives

Articles

+ Understand the differences between various types of breast implants, with a focus on PIP (Poly Implant Prothèse) implants versus medical-grade implants.
+ 
Identify the clinical and systemic health risks related to implant rupture, silicone leakage, and the long-term presence of silicone in the body.
+ Explain the immunological effects of silicone and siloxanes and their suspected link to breast implant illness and cancer.

About the committee

The UK House of Commons Women and Equalities Committee attendees in part 1 are:

Professor Michael Coleman, Professor of Toxicology, Aston University
Professor Prabath Nanayakkara, Professor of Acute Internal Medicine, Amsterdam University Medical Center
Professor Carl Heneghan, Director of the Centre for Evidence-Based Medicine, University of Oxford

The UK House of Commons Women and Equalities Committee attendees in part 1 are:

Professor Michael Coleman, Professor of Toxicology, Aston University
Professor Prabath Nanayakkara, Professor of Acute Internal Medicine, Amsterdam University Medical Center
Professor Carl Heneghan, Director of the Centre for Evidence-Based Medicine, University of Oxford


Articles

About the committee

Watch This Today

Safety In Breast Implants: Insights From The UK Parliament — Part 1: A Scientific Perspective

€29,95 (incl. VAT)

  • Rating: Be the first to rate it
  • Curated version: Enjoy high relevancy
  • CME: Earn 0.5 credit
  • Instant access: Get started after purchase
  • EACCME® accredited: Until 6 March 2027
  • Secure payment: Transactions are encrypted
  • By purchasing, you agree to our GTC Privacy policy
Add to cart Buy now

I'm buying. What's next?

1. Secure checkout page

Click the purchase button and you'll be directed to a secure checkout.

2. Log into your account

Complete your order and locate the talk in your collection after logging in.

3. Start watching

Retrain conveniently, earning CME credit in the process.

Additional information

COMPANY

Home
Library
Share a talk

Our mission

MEMBER

Login
Collection
Settings
Purchase history

SUPPORT

Frequently asked questions
Get in touch
Report issue

CONTACT

Keendoc B.V.
Biltseweg 33
3763 LD Soest
Netherlands
[email protected]

LEGAL

Overview
General terms & conditions
Privacy policy
File a complaint 

COMPANY INFO

CoC: 94795096
VAT ID: NL866894962B01

FOLLOW US

LinkedIn
Youtube